These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15793309)

  • 21. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase.
    Baumbach GL; Sigmund CD; Faraci FM
    Circ Res; 2004 Oct; 95(8):822-9. PubMed ID: 15388643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS; Agata J; Xia CF; Chao L; Chao J
    Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion.
    Schreier B; Börner S; Völker K; Gambaryan S; Schäfer SC; Kuhlencordt P; Gassner B; Kuhn M
    Endocrinology; 2008 Aug; 149(8):4193-9. PubMed ID: 18450968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic Peptide in spontaneously hypertensive rats.
    Romero M; Caniffi C; Bouchet G; Elesgaray R; Laughlin MM; Tomat A; Arranz C; Costa MA
    PLoS One; 2013; 8(8):e71992. PubMed ID: 23951276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
    Kilić A; Bubikat A; Gassner B; Baba HA; Kuhn M
    Endocrinology; 2007 Sep; 148(9):4162-9. PubMed ID: 17510245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.
    Zhang M; Takimoto E; Lee DI; Santos CX; Nakamura T; Hsu S; Jiang A; Nagayama T; Bedja D; Yuan Y; Eaton P; Shah AM; Kass DA
    Circulation; 2012 Aug; 126(8):942-51. PubMed ID: 22829024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evodiamine Inhibits Angiotensin II-Induced Rat Cardiomyocyte Hypertrophy.
    He N; Gong QH; Zhang F; Zhang JY; Lin SX; Hou HH; Wu Q; Sun AS
    Chin J Integr Med; 2018 May; 24(5):359-365. PubMed ID: 28875323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-specific differences in natriuretic peptide and nitric oxide synthase expression in ANP gene-disrupted mice.
    Wong PG; Armstrong DW; Tse MY; Brander EP; Pang SC
    Mol Cell Biochem; 2013 Feb; 374(1-2):125-35. PubMed ID: 23180242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
    Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
    Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
    Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
    Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness.
    Michel K; Herwig M; Werner F; Špiranec Spes K; Abeßer M; Schuh K; Dabral S; Mügge A; Baba HA; Skryabin BV; Hamdani N; Kuhn M
    JCI Insight; 2020 Nov; 5(22):. PubMed ID: 33055420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of ANP and NPR-C mRNA in the kidney and heart of eNOS knockout mice.
    Yuan K; Kim SY; Oh YB; Yu J; Shah A; Park BH; Kim SH
    Peptides; 2010 Jul; 31(7):1319-25. PubMed ID: 20403400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
    Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
    Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase.
    Feng Q; Song W; Lu X; Hamilton JA; Lei M; Peng T; Yee SP
    Circulation; 2002 Aug; 106(7):873-9. PubMed ID: 12176963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice.
    Schipke J; Roloff K; Kuhn M; Mühlfeld C
    Histochem Cell Biol; 2015 Oct; 144(4):365-75. PubMed ID: 26059418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator.
    Elesgaray R; Caniffi C; Savignano L; Romero M; Mac Laughlin M; Arranz C; Costa MA
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1385-94. PubMed ID: 22378819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
    Yamamoto K; Ikeda U; Shimada K
    J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.